NASDAQ: EWTXEdgewise Therapeutics Inc Stock Ownership - Who owns Edgewise Therapeutics?
Insider buying vs selling
Have Edgewise Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John R. 1. Moore | General Counsel | 2024-02-09 | 8,029 | $20.01 | $160.66kSell |
| John R. 1. Moore | General Counsel | 2024-02-09 | 8,029 | $1.93 | $15.50kBuy |
| Behrad Derakhshan | Chief Business Officer | 2024-02-09 | 4,800 | $20.04 | $96.21kSell |
| Behrad Derakhshan | Chief Business Officer | 2024-02-09 | 4,800 | $1.93 | $9.26kBuy |
| Behrad Derakhshan | Chief Business Officer | 2024-02-08 | 4,600 | $1.93 | $8.88kBuy |
| John R. 1. Moore | General Counsel | 2024-02-08 | 3,813 | $20.01 | $76.28kSell |
| John R. 1. Moore | General Counsel | 2024-02-08 | 3,813 | $1.93 | $7.36kBuy |
| Behrad Derakhshan | Chief Business Officer | 2024-02-08 | 4,600 | $20.01 | $92.05kSell |
| John R. 1. Moore | General Counsel | 2024-02-07 | 17,993 | $20.00 | $359.86kSell |
| Behrad Derakhshan | Chief Business Officer | 2024-02-07 | 600 | $1.93 | $1.16kBuy |
EWTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EWTX insiders and whales buy or sell their stock.
EWTX Shareholders
What type of owners hold Edgewise Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Orbimed Advisors LLC | 15.65% | 14,567,176 | $232.20M | Institution |
| Fmr LLC | 6.97% | 6,492,513 | $103.49M | Institution |
| Viking Global Investors LP | 6.61% | 6,159,146 | $98.18M | Institution |
| Novo Holdings A | 6.52% | 6,071,703 | $96.78M | Institution |
| Holdings A. Novo | 6.52% | 6,071,703 | $96.78M | Insider |
| James E. Flynn | 4.22% | 3,933,137 | $62.69M | Insider |
| Deerfield Management Company LP Series C | 4.22% | 3,933,137 | $62.69M | Institution |
| Ecor1 Capital LLC | 3.75% | 3,493,194 | $55.68M | Institution |
| Jonathan D. Root | 3.75% | 3,489,168 | $55.62M | Insider |
| Blackrock Inc | 3.55% | 3,307,110 | $52.72M | Institution |
EWTX vs Biotech Stocks
Edgewise Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.